Heron Therapeutics says its chemo-induced nausea drug successful in clinical trial

29 May 2015

1

Heron Therapeutics Inc said its experimental drug for the treatment of chemotherapy-induced nausea and vomiting (CINV) met its main goal in a late-stage trial.

The company, whose shares were up 41 per cent in extended trading, said it expected to re submit a marketing application for the drug to the US FDA in mid-2015.

Though the company had filed for marketing application for Sustol twice, the FDA had sought additional data.

The drug, Sustol, in combination with two other drugs, was compared with a standard-of-care three-drug regimen and the results revealed that the percentage of patients who achieved the main goal of complete response was significantly higher in the Sustol group.

Business History Videos

History of hovercraft Part 3 | Industry study | Business History

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2 | Industry study | Business History

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1 | Industry study | Business History

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | Industry study | Business History

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more
View details about the software product Informachine News Trackers